JUVELOOK-LENISNA

2 NEW BIOSTIMULATOR PRODUCTS JUVELOOK & LENISNA

Class III injectable medical device (CE 2764). STRICT MEDICAL USE. Refer to the specific product leaflets for further information. Products not included in the list referred to in Article L. 165-1 of the French Social Security Code. Vigilance contact (reporting of an adverse effect): vigilance@fillmed.com.

JUVELOOK & LENISNA THE NEW ERA OF COLLAGEN INDUCTORS. NEW GENERATION TECHNOLOGY TO STIMULATE COLLAGEN FROM WITHIN PDLLA + HA. To address ageing and patient concerns with natural and gradual results Multilayering approach: dermis and subcutaneous tissue. JUVELOOK & LENISNA BIOCOMPATIBLE & BIODEGRADABLE PRODUCTS. A range of 2 products tailored to each patient’s ageing grade with adapted injection depth.

JUVELOOK 50mg/vial

Juvelook is a product designed for very delicate and challenging areas, specifically the eye area (tear trough and lower eyelid), as well as for skin mesotherapy.

• Tear trough
• Skin pore tightening
• Skin texture improvement
• Atrophic scares treatments
• Skin brightening
• Stretch marks treatment

LENISNA 200mg/vial

Lenisna is a product designed for deep, subcutaneous or supraperiosteal administration. The primary technique involves cannula work, but there is an alternative needle procedure available.

• Volume augmentation
• Natural body conturing
• Skin laxity treatment
• Natural face conturing
• Deep scares treatments
• Deep wrinkles treatment

COMPOSITION

PDLLA + ACIDE HYALURONIQUE: A RANGE OF NEW GENERATION COLLAGEN INDUCTORS. DUAL ACTION FOR COLLAGEN REGENERATION GRADUAL STIMULATION & PROTECTION.

INDICATION

High tissue biocompatibility and strong tissue & collagen stimulation.

JUVELOOK DESCRIPTION

JUVELOOK is a device intended for intradermal and subcutaneous implantation to fill skin depressions, restore, and increase soft tissue volume. Its use is recommended for reconstructive purposes in the treatment of morphological asymmetries.

• SKIN QUALITY REJUVENATION FOR UP TO 16 MONTHS.
• REFINE & TIGHTEN To improve skin texture.
• PDLLA particle size 2/4. 20 ~ 40 μm
• REFINE & TIGHTEN To improve skin texture.
• Concentration  50 mg: PDLLA 42.5 mg + HA 7.5 mg.
• Collagen stimulation ••••
• Injection layer Deep dermis.
• For patients with slight ageing & damaged skin quality.
• PROTOCOL 3 sessions spaced out 6 weeks.

LENISNA DESCRIPTION

LENISNA is a device intended for intradermal and subcutaneous implantation to fill skin depressions, restore, and increase soft tissue volume. Its use is recommended for reconstructive purposes in the treatment of morphological asymmetries.

• VOLUME RESTORATION & CONTOURING FOR UP TO 24 MONTHS.
• CONTOUR & LIFT To restore lost volume & improve skin firmness.
• PDLLA particle size "/4 40 ~ 80 μm
• REFINE & TIGHTEN To improve skin texture.
• Concentration  200 mg
• PDLLA 170 mg + HA 30 mg.
• Collagen stimulation ••••
• Injection layer Subcutaneous.
• For patient with skin laxity, sagging & loss of volume.
• PROTOCOL 3 sessions spaced out 8 weeks.

SAFETY

EXCELLENT SAFETY PROFILE & EFFICACY.